| UniProt ID | CDCA3_HUMAN | |
|---|---|---|
| UniProt AC | Q99618 | |
| Protein Name | Cell division cycle-associated protein 3 | |
| Gene Name | CDCA3 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 268 | |
| Subcellular Localization | Cytoplasm, cytosol. | |
| Protein Description | F-box-like protein which is required for entry into mitosis. Acts by participating in E3 ligase complexes that mediate the ubiquitination and degradation of WEE1 kinase at G2/M phase (By similarity).. | |
| Protein Sequence | MGSAKSVPVTPARPPPHNKHLARVADPRSPSAGILRTPIQVESSPQPGLPAGEQLEGLKHAQDSDPRSPTLGIARTPMKTSSGDPPSPLVKQLSEVFETEDSKSNLPPEPVLPPEAPLSSELDLPLGTQLSVEEQMPPWNQTEFPSKQVFSKEEARQPTETPVASQSSDKPSRDPETPRSSGSMRNRWKPNSSKVLGRSPLTILQDDNSPGTLTLRQGKRPSPLSENVSELKEGAILGTGRLLKTGGRAWEQGQDHDKENQHFPLVES | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 6 | Phosphorylation | --MGSAKSVPVTPAR --CCCCCCCCCCCCC | 31.22 | 29396449 | |
| 10 | Phosphorylation | SAKSVPVTPARPPPH CCCCCCCCCCCCCCC | 12.74 | 28985074 | |
| 28 | Methylation | LARVADPRSPSAGIL CHHHCCCCCCCCCEE | 62.84 | - | |
| 29 | Phosphorylation | ARVADPRSPSAGILR HHHCCCCCCCCCEEC | 28.70 | 29255136 | |
| 31 | Phosphorylation | VADPRSPSAGILRTP HCCCCCCCCCEECCC | 40.13 | 30266825 | |
| 36 | Methylation | SPSAGILRTPIQVES CCCCCEECCCEEEEC | 36.21 | - | |
| 37 | Phosphorylation | PSAGILRTPIQVESS CCCCEECCCEEEECC | 22.69 | 30266825 | |
| 43 | Phosphorylation | RTPIQVESSPQPGLP CCCEEEECCCCCCCC | 48.76 | 30266825 | |
| 44 | Phosphorylation | TPIQVESSPQPGLPA CCEEEECCCCCCCCC | 17.66 | 30266825 | |
| 44 | O-linked_Glycosylation | TPIQVESSPQPGLPA CCEEEECCCCCCCCC | 17.66 | OGP | |
| 59 | Ubiquitination | GEQLEGLKHAQDSDP HHHCCCCCCCCCCCC | 47.99 | - | |
| 64 | Phosphorylation | GLKHAQDSDPRSPTL CCCCCCCCCCCCCCC | 37.12 | 29255136 | |
| 68 | Phosphorylation | AQDSDPRSPTLGIAR CCCCCCCCCCCCEEC | 27.85 | 29255136 | |
| 70 | Phosphorylation | DSDPRSPTLGIARTP CCCCCCCCCCEECCC | 38.57 | 22167270 | |
| 76 | Phosphorylation | PTLGIARTPMKTSSG CCCCEECCCCCCCCC | 20.79 | 25159151 | |
| 79 | Methylation | GIARTPMKTSSGDPP CEECCCCCCCCCCCC | 46.59 | - | |
| 80 | Phosphorylation | IARTPMKTSSGDPPS EECCCCCCCCCCCCC | 23.13 | 23403867 | |
| 81 | Phosphorylation | ARTPMKTSSGDPPSP ECCCCCCCCCCCCCH | 27.14 | 23403867 | |
| 82 | Phosphorylation | RTPMKTSSGDPPSPL CCCCCCCCCCCCCHH | 53.07 | 30266825 | |
| 87 | Phosphorylation | TSSGDPPSPLVKQLS CCCCCCCCHHHHHHH | 35.93 | 19664994 | |
| 94 | Phosphorylation | SPLVKQLSEVFETED CHHHHHHHHHHCCCC | 29.26 | 22167270 | |
| 99 | Phosphorylation | QLSEVFETEDSKSNL HHHHHHCCCCCCCCC | 33.36 | 30266825 | |
| 102 | Phosphorylation | EVFETEDSKSNLPPE HHHCCCCCCCCCCCC | 31.58 | 22167270 | |
| 159 | Phosphorylation | KEEARQPTETPVASQ HHHHCCCCCCCCCCC | 44.12 | 17525332 | |
| 161 | Phosphorylation | EARQPTETPVASQSS HHCCCCCCCCCCCCC | 26.07 | 25159151 | |
| 165 | Phosphorylation | PTETPVASQSSDKPS CCCCCCCCCCCCCCC | 30.72 | 17525332 | |
| 167 | Phosphorylation | ETPVASQSSDKPSRD CCCCCCCCCCCCCCC | 37.70 | 30266825 | |
| 168 | Phosphorylation | TPVASQSSDKPSRDP CCCCCCCCCCCCCCC | 41.85 | 30266825 | |
| 170 | Ubiquitination | VASQSSDKPSRDPET CCCCCCCCCCCCCCC | 47.01 | - | |
| 172 | Phosphorylation | SQSSDKPSRDPETPR CCCCCCCCCCCCCCC | 55.87 | 30266825 | |
| 177 | Phosphorylation | KPSRDPETPRSSGSM CCCCCCCCCCCCCCC | 29.41 | 17525332 | |
| 180 | Phosphorylation | RDPETPRSSGSMRNR CCCCCCCCCCCCCCC | 40.01 | 25627689 | |
| 181 | Phosphorylation | DPETPRSSGSMRNRW CCCCCCCCCCCCCCC | 35.85 | 25159151 | |
| 183 | Phosphorylation | ETPRSSGSMRNRWKP CCCCCCCCCCCCCCC | 19.27 | 25159151 | |
| 189 | Ubiquitination | GSMRNRWKPNSSKVL CCCCCCCCCCCCCCC | 30.96 | - | |
| 199 | Phosphorylation | SSKVLGRSPLTILQD CCCCCCCCCCEEEEC | 23.59 | 29255136 | |
| 202 | Phosphorylation | VLGRSPLTILQDDNS CCCCCCCEEEECCCC | 24.03 | 30266825 | |
| 209 | Phosphorylation | TILQDDNSPGTLTLR EEEECCCCCCCEEEE | 31.53 | 29255136 | |
| 212 | Phosphorylation | QDDNSPGTLTLRQGK ECCCCCCCEEEECCC | 21.69 | 25463755 | |
| 214 | Phosphorylation | DNSPGTLTLRQGKRP CCCCCCEEEECCCCC | 21.52 | 29255136 | |
| 219 | Ubiquitination | TLTLRQGKRPSPLSE CEEEECCCCCCCCCC | 53.44 | - | |
| 222 | Phosphorylation | LRQGKRPSPLSENVS EECCCCCCCCCCCHH | 42.37 | 30266825 | |
| 225 | Phosphorylation | GKRPSPLSENVSELK CCCCCCCCCCHHHHH | 30.43 | 20068231 | |
| 229 | Phosphorylation | SPLSENVSELKEGAI CCCCCCHHHHHCCCC | 49.12 | 29978859 | |
| 232 | Ubiquitination | SENVSELKEGAILGT CCCHHHHHCCCCCCC | 50.48 | - | |
| 239 | Phosphorylation | KEGAILGTGRLLKTG HCCCCCCCCCHHHCC | 18.71 | 28555341 | |
| 268 | Phosphorylation | QHFPLVES------- CCCCCCCC------- | 37.73 | 25159151 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CDCA3_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CDCA3_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CDCA3_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| SKP1_HUMAN | SKP1 | physical | 12679038 | |
| CUL1_HUMAN | CUL1 | physical | 12679038 | |
| WEE1_HUMAN | WEE1 | physical | 12679038 | |
| SKP1_HUMAN | SKP1 | physical | 15070733 | |
| A4_HUMAN | APP | physical | 21832049 | |
| PLOD1_HUMAN | PLOD1 | physical | 22939629 | |
| NMT1_HUMAN | NMT1 | physical | 26186194 | |
| FZR1_HUMAN | FZR1 | physical | 26186194 | |
| CTDSL_HUMAN | CTDSPL | physical | 26186194 | |
| VATC1_HUMAN | ATP6V1C1 | physical | 26186194 | |
| LTOR4_HUMAN | LAMTOR4 | physical | 26186194 | |
| CNEP1_HUMAN | CTDNEP1 | physical | 26186194 | |
| CTDSL_HUMAN | CTDSPL | physical | 28514442 | |
| FZR1_HUMAN | FZR1 | physical | 28514442 | |
| VATC1_HUMAN | ATP6V1C1 | physical | 28514442 | |
| CHM4A_HUMAN | CHMP4A | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-87; SER-94 AND SER-199,AND MASS SPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-87, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-29; SER-31; THR-37;SER-44; SER-64; SER-68; THR-76; SER-87; SER-199 AND SER-209, AND MASSSPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-68; SER-199 AND SER-209,AND MASS SPECTROMETRY. | |
| "Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-68; THR-70; SER-199;THR-202 AND SER-209, AND MASS SPECTROMETRY. | |
| "ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-159; SER-165 ANDTHR-177, AND MASS SPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-68; SER-199 AND SER-209,AND MASS SPECTROMETRY. | |